Join us at Advances in the Treatment Paradigm of Myeloid Malignancies: From Biology to Clinical Practice

Plan to attend this complimentary CME satellite symposium that provides an in-depth and up-to-date review of research related to the biology, prognosis, natural history, and therapeutic management of patients with AA, PNH, MDS, AML, MPN and related myeloid malignancies. The overall goal of the program is to bring together leaders in disease research and clinical practice to explore solutions to improving the care of these patient populations.

By attending, you will be able to:

• Describe risk factors and implications of clonal hematopoiesis and potential strategies to modify the natural history of clonal hematopoiesis.
• Outline best available evidence in managing patients with PNH.
• Formulate appropriate evaluation and management strategies for patients with aplastic anemia and other bone marrow failure conditions.
• Critically review the MDS diagnostic criteria in light of recent changes in disease nomenclature and describe expanding treatment strategies for low-risk and high-risk MDS.
• Describe the new diagnostic criteria for AML and how to make personalized treatment decisions in patients with AML.  
• Critically appraise the indications, efficacy, and adverse events for the expanding treatment options for patients with myeloproliferative neoplasms.
• Synthesize current research on the role of cellular therapies in AML and their future potential.

Who Should Attend?

The satellite symposium is designed for an international audience including medical oncologists, hematologists, clinical and translational researchers, and other physicians, nurses, advanced practice nurses, physician assistants and allied health care professionals treating patients with MDS, AML and myeloid malignancies. In addition, members of patient advocacy groups will benefit from this program.

This is a Friday Satellite Symposium organized by the Cleveland Clinic Taussig Cancer Institute and the Aplastic Anemia and MDS International Foundation, Inc., preceding the 65th ASH Annual Meeting and Exposition. ASH Annual Meeting registration is not required to participate in the symposium.